self microemulsifying drug delivery system: a method …
TRANSCRIPT
www.wjpr.net Vol 5, Issue 7, 2016.
578
Ghule et al. World Journal of Pharmaceutical Research
SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM: A
METHOD FOR ENHANCEMENT OF BIOAVAILABILITY
Poonam Kailas Ghule*, Sadik F. Sayyad and Dr. Sanjay R. Chaudhari
Savitribai Phule Pune University, Pune, Amrutvahini Sheti and Shikshan Vikas Sanstha’s,
Amrutvahini College of Pharmacy, Amrutnagar, Sangamner, Maharashtra 2015 – 2016.
ABSTRACT[1-3]
Most of the modern drugs are poorly aqueous soluble, having high
molecular weight, pre systemic first pass effect, enzymatic degradation
and limited dissolution rate shows low bioavailability. The newer and
novel technologies developed in recent year to overcome such
problems. One of the most new way for such a mentioned problem is
the Self microemulsifying drug delivery system (SMEDDS). The
SMEDDS are the isotropic mixture of oil, surfactant and co-surfactant.
SMEDDS solve the problem of all BCS class of drug such as
solubility, high molecular weight, pre systemic first pass effect,
enzymatic degradation, gastric irritation and also increase the
bioavailability and stability of drug. SMEDDS are complex mixtures in
which drug quantification can become a challenging task. The
hypothesis behind dissolution rate enhancement with SMEDDS is the
spontaneous formation of the emulsion in the gastrointestinal tract which presents the drug in
solubilized form, and the small size of the formed droplet provides a large interfacial surface
area for drug absorption.. This article gives a complete overview of SMEDDS as a promising
approach to effectively tackle the problem of poorly soluble molecules.
KEYWORDS: Self micro emulsifying drug delivery system, oral bioavailability, lipid based
formulations, poorly water soluble drugs.
INTRODUCTION[2-4]
Self micro emulsifying drug delivery system (SMEDDS) are defined as isotropic mixtures of
natural or synthetic oils, solid or liquid surfactants, or alternatively, one or more hydrophilic
solvents and co-solvents/surfactants that have a unique ability of forming fine oil-in-water
World Journal of Pharmaceutical Research SJIF Impact Factor 6.805
Volume 5, Issue 7, 578-590. Review Article ISSN 2277– 7105
*Corresponding Author
Poonam Kailas Ghule
Savitribai Phule Pune
University, Pune,
Amrutvahini Sheti and
Shikshan Vikas Sanstha’s,
Amrutvahini College of
Pharmacy, Amrutnagar,
Sangamner, Maharashtra
2015 – 2016.
Article Received on
13 May 2016,
Revised on 03 June 2016,
Accepted on 24 June 2016
DOI: 10.20959/wjpr20167-6613
www.wjpr.net Vol 5, Issue 7, 2016.
579
Ghule et al. World Journal of Pharmaceutical Research
(o/w) micro emulsions upon mild agitation followed by dilution in aqueous media, such as GI
fluids.[1]
SMEDDS spread readily in the GI tract, and the digestive motility of the stomach
and the intestine provide the agitation necessary for self-emulsification. SMEDDS form
transparent micro emulsions with a droplet size of less than 50 nm also the concentration of
oil in SMEDDS is less than 20 % as compared to 40-80% in SEDDS. When compared with
emulsions, which are sensitive and metastable dispersed forms, SMEDDS are physically
stable formulations that are easy to manufacture. Thus, for lipophilic drug compounds that
exhibit dissolution rate-limited absorption, these systems may offer an improvement in the
rate and extent of absorption and result in more reproducible blood-time profiles. SMEDDS
formulation is in theory, comparatively simple. The key step is to find a suitable oil surfactant
mixture that can dissolve the drug within the required therapeutic concentration. The
SMEDDS mixture can be filled in either soft or hard gelatin capsules. A typical SMEDDS
formulation contains oils, surfactants and if required an antioxidants. Often co-surfactants
and co-solvents are added to improve the formulation characteristics.
ADVANTAGES OF SMEDDS
1. Enhanced oral bioavailability enabling reduction in dose[18]
2. Selective targeting of drug(s) towards specific absorption window in GIT.[2]
3. Protection of drug(s) from the hostile environment in gut.[9]
4. Reduced variability including food effects.[13]
5. Protection of sensitive drug substances.
6. Liquid or solid dosage forms.
7. In SMEDDS, the lipid matrix interacts readily with water, forming a fine particulate oil-
in-water (o/w) emulsion. The emulsion droplets will deliver the drug to the
gastrointestinal mucosa in the dissolved state readily accessible for absorption. Therefore
increase in AUC i.e. bioavailability and C max is observed with many drugs when
presented in SMEDDS.
8. Fine oil droplets empty rapidly from the stomach and promote wide distribution of drug
throughout the intestinal tract and thereby minimizing irritation frequently encountered
with extended contact of drugs and gut wall.[9]
9. Ease of manufacture and scale up is one of the most important advantage that make
SMEDDS unique when compared to other drug delivery system like solid dispersion,
liposomes, nanoparticles etc.
www.wjpr.net Vol 5, Issue 7, 2016.
580
Ghule et al. World Journal of Pharmaceutical Research
10. SMEDDS has potential to deliver peptides that are processed to enzymatic hydrolysis in
GIT.
11. When polymer is incorporated in composition of SMEDDS it gives prolonged release of
medicament.[5]
12. SMEDDS formulation is composed of lipids, surfactants and co-solvents. The system has
the ability to form an oil-on-water emulsion when dispersed by an aqueous phase under
gentle agitation. SMEDDS present drugs in a small droplet size and well-proportioned
distribution and increase the dissolution and permeability. Furthermore, because drugs
can be loaded in the inner phase and delivered to the lymphatic system, can bypass first
pass metabolism. Thus SMEDDS protect drugs against hydrolysis by enzymes in the GI
tract and reduce the presystemic clearance in the GI mucosa and hepatic first-pass
metabolism.
DISADVANTAGES OF SMEDDS[1-5]
1. One of the obstacles for the development of SMEDDS and other lipid-based formulations
is the lack of good predicative in vitro models for assessment of the formulations.
2. Traditional dissolution methods do not work, because these formulations potentially are
dependent on digestion prior to release of the drug.
3. This in vitro model needs further development and validation before its strength can be
evaluated.
4. Further development will be based on in vitro - in vivo correlations and therefore different
prototype lipid based formulations needs to be developed and tested in vivo in a suitable
animal model.
5. The drawbacks of this system include chemical instabilities of drugs and high surfactant
concentrations in formulations (approximately 30-60%) which irritate GIT.
6. Moreover, volatile co solvents in the conventional self-micro emulsifying formulations
are known to migrate into the shells of soft or hard gelatin capsules, resulting in the
precipitation of the lipophilic drugs.
7. The precipitation tendency of the drug on dilution may be higher due to the dilution effect
of the hydrophilic solvent.
8. Formulations containing several components become more challenging to validate.
www.wjpr.net Vol 5, Issue 7, 2016.
581
Ghule et al. World Journal of Pharmaceutical Research
COMPOSITION OF SMEDDS[2-5]
The SMEDDS composed of the oil and surfactant. The ratio of concentration of the oil and
surfactant depends upon the solubility of the drug and self emulsifying ability. The nature of
oil, concentration of surfactant and the temperature at which self emulsification occur is also
important during the formulation of SMEDDS. Preformulation studies are carried out for the
selection of oil, surfactant and co-surfactant as these are specific for a particular SMEDDS.
First we govern solubility of drug in various oils and surfactant/co-surfactant then prepare a
series of SMEDDS system containing drug in various oils and surfactants/co-surfactants. By
constricting the Pseudo-ternary phase diagram we identify the efficient self -emulsification
region.
1. OILS
One of the most important excipients because oil can solubilise the lipophilic drug in a
specific amount and it can facilitate self emulsification and increase the fraction of lipophilic
drug transported via the intestinal lymphatic system, mainly the long chain and medium chain
triglycerides are use. The concentration of oil present in SMEDDS is about the 40 to 80 % the
modified and hydrolyzed vegetable oils widely because they show the more solubility and
good self emulsifying property. Solvent capacity for less hydrophobic drugs can be improved
by blend in gtriglycerides with mono- and di-glycerides.
2. SURFACTANTS
The surfactant is the important for the solubilisation of the drug in the oil and they commonly
use as the emulsifier in this system. The various surfactants are using in this system mainly
the non-ionic surfactants. The non-ionic surfactants have the ability to from the self
emulsification in gastric medium also the non ionic surfactant having the less toxicity. The
non-ionic surfactant cause the reversible changes in the permeability of the intestinal lumen.
The concentration of surfactant is most important parameter because the self emulsification
of SMEDDS is depends up on the concentration ratio of oil and surfactant. The concentration
of surfactant is about the 30 to 60 % in SMEDDS and the HLB value of non ionic surfactant
is about >12. The large quantity of the surfactant may cause the gastric irritation. The droplet
size depends up on the concentration of surfactant. The mean droplet size is increase with
increasing the surfactant concentration. This could be attributed to the interfacial disruption
elicited by enhanced water penetration into the oil droplet mediated by the increased
surfactant concentration and leading to ejection of oil droplets into the aqueous phase. The
www.wjpr.net Vol 5, Issue 7, 2016.
582
Ghule et al. World Journal of Pharmaceutical Research
surfactants used in these formulations are known to improve the bioavailability by various
mechanisms including: improved drug dissolution, increased intestinal epithelial
permeability, increased tight junction permeability.
3. CO-SURFACTANT
For the fabrication of an optimum SMEDDS, high concentration of surfactant is required in
order to reduce interfacial tension sufficiently, which can be harmful, so co-surfactants are
used to shrink the concentration of surfactants. Co-surfactants together with the surfactants
afford the sufficient litheness to interfacial film to take up different curvatures required to
form micro-emulsion over a wide range of composition. Selection of proper surfactant and
co-surfactant is necessary for the efficient design of SMEDDS and for the solubilisation of
drug in the SMEDDS. Organic solvents like ethanol, propylene glycol, polyethylene glycol
are able to dissolve large amount of either drug or hydrophilic surfactant in lipid base and are
suitable for oral delivery, so they can be used as co-surfactant for SMEDDS. Alternately
alcohols and other volatile co-solvents show a disadvantage that by evaporation they get
entered into soft/hard gelatin capsule shells resulting in precipitation of drug. On the other
hand formulations which are free from alcohols have limited lipophilic drug dissolution
ability. Hence, appropriate choice of components has to be made for formulation of efficient
SMEDDS. Hydrophilic co-surfactants are preferably alcohols of intermediate chain length
such as hexanol, pentanol and octanol, which are known to reduce the oil/water interface and
allow the spontaneous formulation of micro emulsion.
CONSTRUCTION OF TERNARY PHASE DIAGRAMS[15-18]
Ternary phase diagram is useful to identify best emulsification region of Oil, Surfactant and
Co-Surfactant combinations. Ternary phase diagram of surfactant, co-surfactant and oil will
plot; each of them, representing an apex of the triangle. The methods are used to plot Ternary
phase diagrams are namely Dilution method and Water Titration method.
DILUTION METHOD
Ternary mixtures with varying compositions of surfactant, co-surfactant and oil will be
equipped. The surfactant concentration will diverge from 30 to 75% (w/w), oil concentration
will diverge from 25 to 75% and co-surfactant concentration will diverge from 0 to 30%
(w/w). For any mixture, the total of surfactant, co-surfactant and oil concentrations always
added to 100%. For example, in the experiment, first mixture consisted of 75% of surfactant,
25% of the oily phase and 0% of co-surfactant. Further, the co-surfactant was increased by
www.wjpr.net Vol 5, Issue 7, 2016.
583
Ghule et al. World Journal of Pharmaceutical Research
5% for each composition, oily phase concentration will keep constant and the surfactant
concentration will adjust to make a total of 100%. Forty-two such mixtures with varying
surfactant, co-surfactant and oil concentrations will prepare. The percentage of surfactant, co-
surfactant and oil used herein will decide on the basis of the requirements. Compositions are
evaluated for nanoemulsion formation by diluting appropriate amount of mixtures with
appropriate double distilled water. Globule size of the resulting dispersions will be
determined by using spectroscopy technique. Dispersions, having globule size 200 nm or
below will consider desirable. The area of nanoemulsion formation in Ternary phase diagram
will identified for the respective system in which nanoemulsions with desire globule size
were obtain.
WATER TITRATION METHOD
The pseudo-ternary phase diagrams were also constructed by titration of homogenous liquid
mixtures of oil, surfactant and co-surfactant with water at room temperature. Oil phase,
Surfactant and the co-surfactant (surfactant: co-surfactant ratio) were prepared varied from
9:1 to 1:9 and weighed in the same screw-cap glass tubes and were vortexed. Each mixture
was then slowly titrated with aliquots of distilled water and stirred at room temperature to
attain equilibrium. The mixture was visually examined for transparency. After equilibrium
was reached, the mixtures were further titrated with aliquots of distilled water until they
showed the turbidity. Clear and isotropic samples were deemed to be within the
microemulsion region. No attempts were made to completely identify the other regions of the
phase diagrams. Based on the results, appropriate percentage of oil, surfactant and co-
surfactant was selected, correlated in the phase diagram and were used for preparation of
SMEDDS.
PREPARATIONS OF SMEDDS FORMULATIONS
SMEDDS was prepared according to recently reported method. Variable proportions of oil,
surfactant and co-surfactant were added into a 10 ml screw capped glass tube, and the
components were mixed by gentle stirring. After complete dissolution, SMEDDS, a clear and
transparent solution, was obtained. Based on the results of above experiment and the reported
concentration scope of three ingredients forming SMEDDS, the contents of surfactant, co-
surfactant and oil were chosen at the range of 30-65%, 30-65% and 5-40%, respectively, in
order to obtain the optimal formulation of SMEDDS. Now a days for optimization and design
www.wjpr.net Vol 5, Issue 7, 2016.
584
Ghule et al. World Journal of Pharmaceutical Research
of SMEDDS the surface methodology, modified simplex method and box- bechnken design
optimization techniques use.
ABSORPTION OF SMEDDS[2-4]
Generally the SMEDDS causes the stimulation of intestinal lymphatic transport. For highly
lipophilic drugs, lipids may enhance the extent of lymphatic transport and increase
bioavailability directly or indirectly via a reduction in first‐pass metabolism. Increases in
effective luminal drug solubility. The presence of lipids in the GI tract stimulates an increase
in the secretion of bile salts (BS) and endogenous biliary lipids including phospholipids (PL)
and cholesterol (CH), leading to the formation of BS/PL/CH intestinal mixed micelles and an
increase in the solubilisation capacity of the GI tract. However, intercalation of administered
(exogenous) lipids into these BS structures either directly (if sufficiently polar), or secondary
to digestion, leads to swelling of the micelle structures and a further increase in solubilisation
capacity. Changes in the biochemical barrier function of the GI tract. It is clear that certain
lipids and surfactants may attenuate the activity of intestinal efflux transporters, as indicated
by the p‐glycoprotein efflux pump, and may also reduce the extent of enterocyte ‐based
metabolism. -Rapid dispersion of self-emulsifying systems -Increased solubility and
promotion of super saturation - Inceasesing residence time - Potential effects on intestinal-
based efflux and permeability - Potential influence of drug metabolism in the intestine.
Potential effect of lipid drug delivery system on oral drug absorption
www.wjpr.net Vol 5, Issue 7, 2016.
585
Ghule et al. World Journal of Pharmaceutical Research
MECHANISM OF SELF EMULSIFICATION[5-7]
In emulsification process the free energy (ΔG) associated is given by the equation: ΔG =
ΣNiπri2σ In which “N” is number of droplets with radius “r” and “σ” is interfacial energy. It
is apparent from equation that the spontaneous formation of the interface between the oil and
water phase is energetically not favored. The system commonly classified as SEDDS have
not yet been shown to emulsify spontaneously in the thermodynamic sense. The process of
self-emulsification was observed using light microscopy. The emulsification process may be
associated with the ease with water penetrates the oil-water interface with the formation of
liquid crystalline phases resulting in swelling at the interface thereby resulting in greater ease
of emulsification. The additional mechanisms by which lipid based delivery systems enhance
the absorption of lipophilic drugs are.
ENHANCED DISSOLUTION/SOLUBILIZATION
The presence of lipids in the GI tract stimulates gallbladder contractions and biliary and
pancreatic secretions including bile salts (BS), phospholipids (PL) and cholesterol. These
products, along with the gastric shear movement, form a crude emulsion which promotes the
solubilization of the coadministered lipophilic drug. Lipids in the GI tract provoke delay in
gastric emptying, i.e. gastric transit time is increased. As a result, the residence time of the
co-administered lipophilic drug in the small intestine increases that enables better dissolution
of the drug.
RECENT ADVANCEMENTS IN SMEDDS SELF-EMULSIFYING SUSTAINED/
CONTROLLED-RELEASE TABLETS[10-15]
Numerous potent drugs exhibit low oral bioavailability due to their poor aqueous solubilities
or presystemic metabolism. Carvedilol one of those drug having low bioavailability, low
solubility and having pre systemic metabolism. The novel self-emulsifying osmotic pump
tablet (SEOPT) containing carvedilol has many advantages. It improves the bioavailability of
carvedilol, controls the release rate and makes the plasma concentrations more stable. The
results of dissolution experiment showed that the release of carvedilol from self-made EOPT
was controlled and complete and its profile was close to zero order releas.
SELF-EMULSIFYING CAPSULE
It is a capsules containing liquid or semisolid form of self emulsifying system. In the GIT, the
capsules get dispersed to SES uniformly in the fluid to micron size, enhancing bioavailability.
Second type of self emulsifying capsule is solid SES filled into capsule.
www.wjpr.net Vol 5, Issue 7, 2016.
586
Ghule et al. World Journal of Pharmaceutical Research
SELF-EMULSIFYING SUPPOSITORIES
Some investigators proved that Solid-SEDDS could increase not only GI adsorption but also
rectal/vaginal adsorption. Glycyrrhizin, which, by the oral route, barely achieves therapeutic
plasma concentrations, can obtain satisfactory therapeutic levels for chronic hepatic diseases
by either vaginal or rectal SE suppositories. The formulation included glycyrrhizin and a
mixture of a C6–C18 fatty acid glycerol ester and a C6–C18 fatty acid macrogol ester.
SELF-NANO MULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) /SELF-
EMULSIFYING NANOPARTICLES
Nanoparticle techniques have been useful in the production of SE nanoparticles. Solvent
injection is one of these techniques.In this method, the lipid, surfactant, and drugs were
melted together, and injected drop wise into a stirred non-solvent. The resulting SE
nanoparticles were thereafter filtered out and dried. E.glacidipine loaded SNEDDS
formulation so to contain minimum amount of surfactant, maximum amount of lipid, highest
emulsification and dissolution rates.
SELF-EMULSIFYING SUSTAINED/CONTROLLED-RELEASE PELLETS
Pellets, as a multiple unit dosage form, possess many advantages over conventional solid
dosage forms, such as flexibility of manufacture, reduction of intra subject and inter subject
variability of plasma profiles and minimizing GI irritation without lowering drug
bioavailability. Thus, it seems very appealing to combine the advantages of pellets with those
of SEDDS by SE pellets. Spherical pellets with low friability and self-emulsifying properties
can be produced by the standard extrusion/ spheronization technique. E.g Lipid mixtures
composed of Solutol® HS 15 and medium chain glycerides were optimized with respect to
their self-emulsifying properties. The liquid SE lipid was mixed with microcrystalline
cellulose and transformed into pellets by extrusion/spheronization. The pellets were
characterized for size, shape, surface characteristics and friability. The combinations of
coating and SES could control in vitro drug release by providing a range of release rates and
the presence of the SEDDS did not influence the ability of the polymer film to control drug
dissolution.
SELF-EMULSIFYING SOLID DISPERSIONS
Although solid dispersions can increase the dissolution rate and bioavailability of poorly
water-soluble drugs, some manufacturing problems involving stability are continuing targets
for pharmaceutical research. These difficulties could be overcome by the use of SE
www.wjpr.net Vol 5, Issue 7, 2016.
587
Ghule et al. World Journal of Pharmaceutical Research
excipients. SE excipients, likeGelucire1 44/14, Gelucire 50/02, Labrasol, Transcutol and
TPGS (tocopheryl polyethylene glycol 1000succinate), have been widely used to solve the
same problem. Gupta et al. prepared SE solid dispersion granules using the hot-melt
granulation method for seven drugs, including four carboxylic acid containing drugs, a
hydroxyl-containing drug, an amide containing drug (phenacetin) and a drug with no proton
donating groups (progesterone) in which Gelucire 50/13was used as the dispersion carrier,
while Neusilin US2was used as the surface adsorbent. Self-emulsifying beads Solidification
of liquid systems has been a challenge that has attracted wide attention due to handling
difficulties and machinability and stability problems that are often encountered with liquids.
One of the solidification is to transform into SES beds form with minimum amounts of
solidifying excipients, investigated SES as microchannels of porous polystyrene beads (PPB)
using the solvent evaporation method. PPB with complex internal void structure is typically
produced by copolymerizing styrene and divinyl benzene. Porous polymer structures such as
macroporous high internal phase emulsion (HIPE) polymers were used as high-capacity
reservoirs for included liquids and as carriers for active pharmaceuticals for sustained
delivery.
SELF-EMULSIFYING SUSTAINED-RELEASE MICROSPHERES
Zedoary turmeric oil (ZTO) exhibits potent pharmacological actions including tumor
suppression, and antibacterial, and antithrombotic activity. With ZTO as an oil phase, the
solid SE sustained-release microspheres were prepared by the quasi-emulsion-solvent-
diffusion method involving spherical crystallization. The ZTO release behaviour was
controlled by the ratio of hydroxyl- -propyl methyl cellulose acetate succinate to Aerosil 200
in the formulation, and the plasma concentration time-profiles after oral administration to
rabbits showed a bioavailability of 135.6%compared with the conventional liquid SEDDS.
POSITIVELY CHARGED SELF-EMULSIFYINGDRUG DELIVERY SYSTEM
One of the most persistent problems faced by the formulation scientists has been to find
methods of improving the oral bioavailability of poorly water-soluble drugs. This positively
charged SEDDS gives several fold increase in the bioavailability than the negatively charged
one. Cationic lipids are use in this type of system. E.g positively charged Meloxicam SEDDS
were prepared using oil components (ethyl oleate, sunflower oil and arachis oil), cationic
lipid (oleylamine) and surfactants (combination of Tween 80 and Span 80).
www.wjpr.net Vol 5, Issue 7, 2016.
588
Ghule et al. World Journal of Pharmaceutical Research
SELF-DOUBLE-EMULSIFYING DRUG DELIVERY SYSTEM (SDEDDS)
SDEDDS can spontaneously emulsify to water-in-oil in-water (w/o/w) double emulsions in
the mixed aqueous gastrointestinal environment, with drugs encapsulated in the internal water
phase of the double emulsions. We employed SDEDDS to improve the oral absorption of
pidotimod, a peptide-like drug with high solubility and low permeability.
SUPER SATURATABLE SELF-EMULSIFYING DRUG DELIVERY SYSTEM (S-
SEDDS)
The potential for supersaturated drug formulations in improving drug absorption was first
proposed by the T, Higuchii. The polyvinyl pyrrolidone and water soluble cellulosic
polymers such as HPMC, methyl cellulose, hydroxyl propyl methylcellulose phthalate are
useful in generating a super saturatable state with number of poorly water soluble drug. A
high payload super saturatable self-emulsifying drug delivery system (S-SEDDS) was
explored to improve the oral bioavailability of silybin, a poorly water-soluble drug candidate,
employing hydroxyl propyl methyl cellulose (HPMC) as a precipitation inhibitor.
SELF-MICRO EMULSIFYING FLOATING DOSAGE FORM
The main problem regarding the low bioavailability is low solubility, presystemic
metabolism; eradicate absorption of drug throughout GIT. The floating system increases the
residence time of drug in the stomach and develop prolonged-release forms. The novel
floating dosage form of Furosemide (FUR) to enhance its solubility by formulating a self
microemulsifying drug delivery system (SMEDDS) of FUR, followed by its adsorption onto
a mixture of high functionality excipient, matrix forming polymers (HPMC K4M and HPMC
E50 LV) and a gas-generating agent (NaHCO3) to achieve a buoyant matrix with a controlled
release profile.
CONCLUSION
Self - emulsifying drug delivery systems are a promising approach for the formulation of
drug compounds with poor aqueous solubility, having high molecular weight, pre systemic
first pass effect, enzymatic degradation, gastric irritation, having limited dissolution rate and
low bioavailability. This is the method suited for all BCS class drugs where resulting
emulsification gives faster dissolution rates and absorption. With future development of this
technology, SEDDS will continue to enable novel applications in drug delivery and solve
deficiency associated with the delivery of poorly water soluble, high molecular weight, pre
www.wjpr.net Vol 5, Issue 7, 2016.
589
Ghule et al. World Journal of Pharmaceutical Research
systemic first pass effect, enzymatic degradation, gastric irritation, having limited dissolution
rate and low bioavailability.
REFERENCES
1. Tang J: Self-Emulsifying Drug Delivery Systems: strategy for improving oral delivery of
poorly soluble drugs. Cur Drug Th., 2007; 2: 85-93.
2. Khoo SM, Humberstone AJ, Porter CJ, Edwards GA and Charman WN. Formulation
design and bioavailability assessment of lipidic self-emulsifying formulations of
Halofantrine. Int J of Pharm., 1998; 167: 155-164.
3. Kawakami K, Yoshikawa T, Moroto Y, Kanakao E, Takahuani K, Nishihara Y and
Masuda K. Microemulsion formulation for enhanced absorption of poorly soluble
Drugs.I. Prescription design. J of Contr Rel., 2002; 81: 75-82.
4. Cortesi R, Espositi E, Maietti A, Menegatti E and Nastruzzi C. Formulation study for the
antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion. Int J of
Pharm., 1997; 159: 95-103.
5. Karim A, Gokhale R, Cole M, Sherman J, Yeramian P, Bryant M and Franke H. HIV
protease inhibitor SC-52151: a novel method of optimizing bioavailability profile via a
microemulsion drug delivery system. Pharm Research., 1994; 11: S368.
6. Georgakopoulos E, Farah N and Vergnault G. Oral anhydrous non-ionic microemulsions
administered in softgel capsules. B. T. Gattefosse., 1992; 85: 11.
7. wenson ES, Milisen WB and Curatolo W. Intestinal permeability enhancement: efficacy,
acute local toxicity and reversibility. Pharm Res., 1994; 11: 1132-42.
8. Brijesh Chaudhary, Kapil Maheshwari. Self-emulsifying drug delivery system: a novel
approach for enhancement of bioavaibility: Journal of pharmaceutical science and
biosceintific research., 2011; 31-36.
9. Sachan A. Khatri, S. B Kasture. Self-Eumlsifying Drug Delivery System A Novel
Approach for enhancement of Bioavalibility: Int. J of PharmTech Research., 2010;
1738-1745.
10. Angela Sprunk, Clare J. Strachan. Rational formulation development and in vitro
assessment of SMEDDS for oral delivery of poorly water soluble drugs: European
Journal of Pharmaceutical Sciences., 2012; 508-515.
11. Jill B Shukla, Akshay R Koli. self micro emulsifying drug delivery system; pharma
science monitor an international journal of pharmaceutical sciences., 2010; 13-27: 125.
www.wjpr.net Vol 5, Issue 7, 2016.
590
Ghule et al. World Journal of Pharmaceutical Research
12. Ashok R. Patel and Pradeep R. Vavia. Preparation and In Vivo Evaluation of SMEDDS
(Self-Microemulsifying Drug Delivery System) Containing Fenofibrate; The AAPS
Journal., 2007; E344-E351.
13. Anand U. Kyatanwar, Kisan R. Jadhav, Vilasrao J. Kadam. Self micro-emulsifying drug
delivery system (SMEDDS): Journal of Pharmacy Research., 2010; 75-83.
14. Jing Cui, Bo Yu. Enhancement of oral absorption of curcumin by self-microemulsifying
drug delivery systems; Int J of Pharmaceutics., 2009; 148–155.
15. R. NeslihanGursoy, Simon Benita. Self-emulsifying drug delivery systems (SEDDS) for
improved oral delivery of lipophilic drugs; Biomedicine& Pharmacotherapy., 2004;
173–182.
16. Wei Wu, Yang Wang. Enhanced bioavailability of silymarin by self-microemulsifying
drug delivery system: European Journal of Pharmaceutics and Biopharmaceutics., 2006;
288–294.
17. Tao Yi, Jiangling Wan, HuibiXu, A new solid self-microemulsifying formulation
prepared by spray-drying to improve the oral bioavailability of poorly water soluble
drugs: European Journal of Pharmaceutics and Biopharmaceutics., 2008; 439–444.
18. Ping Zhang, Ying Liu. Preparation and evaluation of self-microemulsifying drug delivery
system of oridonin: Int J of Pharmaceutics., 2008; 269–276.